AI Agent Operational Lift for Cancer Prevention And Control Research Network (cpcrn) in Chapel Hill, North Carolina

Why AI matters at this scale

The Cancer Prevention and Control Research Network (CPCRN), a 200+ person research consortium founded in 2002 and based in Chapel Hill, NC, operates at a critical intersection of academia and public health. As a mid-market research entity with an estimated $45M in annual grant-funded revenue, CPCRN coordinates multi-site studies across numerous university health systems. This scale generates a classic data-rich but insight-poor environment. Hundreds of thousands of de-identified patient records, survey responses, and unstructured clinical notes sit across siloed institutional databases. Manual data harmonization, systematic literature reviews, and cross-site analysis are slow, costly, and limit the speed at which evidence-based cancer prevention interventions can be disseminated to communities. AI offers a path to break these bottlenecks without requiring massive enterprise-scale investment, making it a high-leverage proposition for a network of this size.

Accelerating evidence synthesis with NLP

The most immediate and high-ROI opportunity is automating systematic reviews. CPCRN researchers spend months manually screening thousands of abstracts and full-text articles to synthesize evidence on topics like HPV vaccination uptake or colorectal cancer screening. A fine-tuned large language model (LLM) can act as a tireless first-pass screener, extracting key findings and study characteristics. This can cut review time by over 70%, allowing the network to respond faster to emerging cancer prevention science and freeing up investigator time for higher-level analysis and community engagement. The cost is primarily in compute and a part-time data scientist, easily justifiable in a grant supplement.

Unlocking clinical insights through federated learning

CPCRN's core asset is its distributed clinical data. Building centralized predictive models for cancer risk is often impossible due to privacy regulations and institutional data-sharing policies. Federated learning provides a solution: model weights, not patient data, travel between sites. CPCRN can train a robust model to predict, for example, lung cancer screening eligibility gaps across its diverse populations without a single data export. This directly supports the network's mission to reduce disparities by identifying underserved groups for targeted outreach, with the ROI measured in improved screening rates and grant renewals.

Streamlining operations and data harmonization

A less glamorous but critical bottleneck is the manual mapping of disparate electronic health record (EHR) data to a common data model for each new study. Machine learning models can be trained to suggest mappings between local codes and standard terminologies, turning a months-long, error-prone process into a supervised, semi-automated task. This accelerates study startup times and improves data quality, making the network more agile and competitive for future funding.

Deployment risks for a mid-market research network

For a 201-500 person organization, the primary risks are not compute power but talent retention, algorithmic bias, and governance. Attracting and keeping machine learning engineers on academic salaries is challenging; CPCRN should leverage its university partnerships for shared roles. More critically, models trained on biased historical data can perpetuate or even amplify health disparities, directly contradicting CPCRN's equity mission. Rigorous fairness audits and diverse training data are non-negotiable. Finally, a federated governance model across member sites must be established to agree on AI use cases, data use agreements, and model validation standards before any code is written. Starting with a low-risk, high-visibility pilot like the systematic review tool is the safest path to building trust and demonstrating value.